394 related articles for article (PubMed ID: 17501762)
21. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
Ahmad N; Asgher M; Shafique M; Qureshi JA
Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
[TBL] [Abstract][Full Text] [Related]
22. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
[TBL] [Abstract][Full Text] [Related]
23. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.
Bowden S; McCaw R; White PA; Crofts N; Aitken CK
J Viral Hepat; 2005 May; 12(3):322-4. PubMed ID: 15850474
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis G virus co-infection may affect the elimination of hepatitis C virus RNA from the peripheral blood of hemodialysis patients.
Januszkiewicz-Lewandowska D; Wysocki J; Rembowska J; Lewandowski K; Nowak T; Pernak M; Nowak J
Acta Virol; 2001; 45(4):261-3. PubMed ID: 11885935
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.
Mast EE; Hwang LY; Seto DS; Nolte FS; Nainan OV; Wurtzel H; Alter MJ
J Infect Dis; 2005 Dec; 192(11):1880-9. PubMed ID: 16267758
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
[TBL] [Abstract][Full Text] [Related]
27. Follow-up studies of treatment for hepatitis C virus infection among injection drug users.
Dalgard O
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S336-8. PubMed ID: 15768344
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
29. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000.
Hammer GP; Kellogg TA; McFarland WC; Wong E; Louie B; Williams I; Dilley J; Page-Shafer K; Klausner JD
Sex Transm Dis; 2003 Dec; 30(12):919-24. PubMed ID: 14646642
[TBL] [Abstract][Full Text] [Related]
30. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.
Grebely J; Raffa JD; Lai C; Krajden M; Kerr T; Fischer B; Tyndall MW
J Viral Hepat; 2009 May; 16(5):352-8. PubMed ID: 19226330
[TBL] [Abstract][Full Text] [Related]
31. Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients.
Ross RS; Viazov S; Clauberg R; Wolters B; Fengler I; Eveld K; Scheidhauer R; Hüsing J; Philipp T; Kribben A; Roggendorf M
J Viral Hepat; 2009 Apr; 16(4):230-8. PubMed ID: 19175869
[TBL] [Abstract][Full Text] [Related]
32. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
[TBL] [Abstract][Full Text] [Related]
33. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting.
Pham ST; Bull RA; Bennett JM; Rawlinson WD; Dore GJ; Lloyd AR; White PA
Hepatology; 2010 Nov; 52(5):1564-72. PubMed ID: 21038409
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
[TBL] [Abstract][Full Text] [Related]
35. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
Shores NJ; Maida I; Soriano V; Núnez M
J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
[TBL] [Abstract][Full Text] [Related]
36. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
[TBL] [Abstract][Full Text] [Related]
38. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
39. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives.
Scott JD; McMahon BJ; Bruden D; Sullivan D; Homan C; Christensen C; Gretch DR
Clin Infect Dis; 2006 Apr; 42(7):945-52. PubMed ID: 16511757
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.
Amon JJ; Garfein RS; Ahdieh-Grant L; Armstrong GL; Ouellet LJ; Latka MH; Vlahov D; Strathdee SA; Hudson SM; Kerndt P; Des Jarlais D; Williams IT
Clin Infect Dis; 2008 Jun; 46(12):1852-8. PubMed ID: 18462109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
